These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21597551)

  • 1. Cardiovascular absolute risk assessment -- a research journey in general practice.
    Zwar N; Harris MF; Denney-Wilson E
    Aust Fam Physician; 2011 May; 40(5):309. PubMed ID: 21597551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular absolute risk assessment and management - engagement and outcomes in general practice patients.
    Wan Q; Zwar N; Vagholkar S; Campbell T; Harris M
    Aust Fam Physician; 2010 Dec; 39(12):954-8. PubMed ID: 21301679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice.
    Wan Q; Harris MF; Zwar N; Campbell T; Patel A; Vagholkar S; McKenzie S; Walker C; Denney-Wilson E;
    Am Heart J; 2009 Mar; 157(3):436-41. PubMed ID: 19249412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prerequisites for implementing cardiovascular absolute risk assessment in general practice: a qualitative study of Australian general practitioners' and patients' views.
    Wan Q; Harris MF; Zwar N; Vagholkar S; Campbell T
    J Eval Clin Pract; 2010 Jun; 16(3):580-4. PubMed ID: 20438609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk assessment in Australian general practice.
    Gupta R; Stocks NP; Broadbent J
    Aust Fam Physician; 2009 May; 38(5):364-8. PubMed ID: 19458809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPs' views of absolute cardiovascular risk and its role in primary prevention.
    Torley D; Zwar N; Comino EJ; Harris M
    Aust Fam Physician; 2005 Jun; 34(6):503-4, 507. PubMed ID: 15931411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can general practitioners provide effective cardiovascular disease (CVD) prevention? Dreams and realities of CVD prevention.
    Gill E; Mangin D
    N Z Med J; 2011 Jan; 124(1328):72-81. PubMed ID: 21475341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the proportion of Danes at high risk of fatal cardiovascular disease.
    Holm AS; Olsen GS; Borglykke A; Jørgensen T
    Scand J Public Health; 2011 Aug; 39(6):571-6. PubMed ID: 21737477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM; Segura J
    Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of cardiovascular diseases in general practice: mismatch between cardiovascular risk and patients' risk perceptions.
    van der Weijden T; van Steenkiste B; Stoffers HE; Timmermans DR; Grol R
    Med Decis Making; 2007; 27(6):754-61. PubMed ID: 17873263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.